Feasibility and safety results from RAD-IO: a multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.

James, N.D., van de Wiel, J., Hughes, A. et al. (11 more authors) (2025) Feasibility and safety results from RAD-IO: a multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer. In: Journal of Clinical Oncology. 2025 ASCO Genitourinary Cancers Symposium, 13-15 Feb 2025, San Francisco CA, USA. , p. 778.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • James, N.D.
  • van de Wiel, J.
  • Hughes, A.
  • Hodgkins, A.-M.
  • Hafeez, S.
  • Zarkar, A.
  • De Santis, M.
  • Din, O.S.
  • Mir, R.
  • Iddenden, J.
  • Bonner, C.V.
  • Pirrie, S.
  • Magwaro, S.
  • Hussain, S.A. ORCID logo https://orcid.org/0000-0003-1552-511X
Copyright, Publisher and Additional Information:

© 2025 by American Society of Clinical Oncology.
Keywords: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunotherapy; Patient Safety; Clinical Research; Cancer; Urologic Diseases; Radiation Oncology; Clinical Trials and Supportive Activities; Pharmaceuticals; Radiotherapy and other non-invasive therapies; Cancer; Good Health and Well Being
Dates:
  • Published (online): 18 February 2025
  • Published: 10 February 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 07 May 2025 14:33
Last Modified: 07 May 2025 14:33
Status: Published
Refereed: Yes
Identification Number: 10.1200/jco.2025.43.5_suppl.778
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)